Seems like things took a swift U-turns days after the Supreme president Donald Trump had a friendly visit to India where he received an overwhelming welcome from Modi’s home town. While the United States of America blazing with the increasing number of Corona deaths, President Donald Trump on Monday warned India of retaliation if the anti-malaria drug Hydroxychloroquine is not supplied to the US.
This move came hours after the Indian government the export of the anti-malarial drug. Stating that he sought help from the Modi-led Indian government, Trump stated that he would be surprised if India did not allow the export of the specified drug. “If he(Modi) doesn’t allow it(Hydroxychloroquine) to come out, that would be okay, but of course there may be retaliation. Why wouldn’t there be?” Trump told reporters during a press briefing at the White House on Monday.
His remarks came as a jolt to Indian government while the country itself is struggling to tackle the increasing number of positive cases. Meanwhile, it was learnt that the Indian government has decided to partially lift the ban on the export of two key drugs, hydroxychloroquine and paracetamol, to clear all existing orders. “All existing orders will be cleared. The Ministry of External Affairs and Department of Pharma will decide on such allocations depending on humanitarian (COVID) situation,” the source added.
Does this mean that India is coming down to the threat-of-sort made by the U.S. government? India has received similar requests from several other countries including its immediate neighbours Sri Lanka and Nepal.